Blood Res 2022; 57(S1):
Published online April 30, 2022
https://doi.org/10.5045/br.2022.2022068
© The Korean Society of Hematology
Correspondence to : Young Hoon Park, M.D.
Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea
E-mail: carrox2yh@gmail.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thrombocytopenia, defined as platelet count <150×109/L, is frequently observed by physicians during pregnancy, with an incidence of approximately 10% of all pregnancies. Most of the cases of thrombocytopenia in pregnancy are due to gestational thrombocytopenia, which does not confer an increased risk of maternal bleeding. However, because other causes can be associated with life-threatening events, such as severe bleeding, that can affect to maternal and fetal outcomes, differentiating other cause of thrombocytopenia, which includes preeclampsia, HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome, acute fatty liver of pregnancy, immune thrombocytopenia, hereditary thrombocytopenia, antiphospholipid syndrome, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome, is important. Understanding the mechanisms and recognition of symptoms and signs are important to decide an adequate line of investigation. In this review, the approach to diagnosis and the management of the thrombocytopenia commonly observed in pregnancy are presented.
Keywords Thrombocytopenia, Pregnancy, Management
Blood Res 2022; 57(S1): S79-S85
Published online April 30, 2022 https://doi.org/10.5045/br.2022.2022068
Copyright © The Korean Society of Hematology.
Young Hoon Park
Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea
Correspondence to:Young Hoon Park, M.D.
Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea
E-mail: carrox2yh@gmail.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thrombocytopenia, defined as platelet count <150×109/L, is frequently observed by physicians during pregnancy, with an incidence of approximately 10% of all pregnancies. Most of the cases of thrombocytopenia in pregnancy are due to gestational thrombocytopenia, which does not confer an increased risk of maternal bleeding. However, because other causes can be associated with life-threatening events, such as severe bleeding, that can affect to maternal and fetal outcomes, differentiating other cause of thrombocytopenia, which includes preeclampsia, HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome, acute fatty liver of pregnancy, immune thrombocytopenia, hereditary thrombocytopenia, antiphospholipid syndrome, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome, is important. Understanding the mechanisms and recognition of symptoms and signs are important to decide an adequate line of investigation. In this review, the approach to diagnosis and the management of the thrombocytopenia commonly observed in pregnancy are presented.
Keywords: Thrombocytopenia, Pregnancy, Management
Table 1 . Laboratory abnormalities by cause of thrombocytopenia..
GT | ITP | HT | TTP | aHUS | PEC | HELLP | AFLP | APS | |
---|---|---|---|---|---|---|---|---|---|
CBC | |||||||||
PLT (×109/L) | ≥75 | Any, variable | 20–130 | <100 | 20–150 | >50 (<50 in <5%) | 50–100 | >50 | ≥50 |
Hemoglobin | - | - | - | ↓↓ | ↓↓ | -/↓ | -/↓ | - | - |
PBS | - | ±Few large PLTs | ±Giant PLT or small PLTs ±WBC inclusions | Schistocytes +++ | Schistocytes +++ | ±Schistocytes | ±Schistocytes | - | ±Schistocytes |
LDH | - | - | - | ↑↑↑↑ | ↑↑↑ | ↑ | ↑↑ | ↑↑↑ | - |
Creatinine | - | - | - | -/↑ | ↑↑↑ | -/↑ | ↑ | -/↑ | -/↑ |
AST/ALT | - | - | - | -/↑ | -/↑ | - | ↑↑↑ | ↑↑↑ | -/↑ |
Bilirubin | |||||||||
Direct | - | - | - | ↑↑ | ↑↑ | -/↑ | ↑↑ | ↑↑ | - |
Indirect | - | - | - | ↑↑ | ↑ | - | |||
PT/aPTT | - | - | - | - | - | -/↑ | ↑ | ↑↑ | -/↑ |
Urine protein | - | - | - | - | ↑ | ↑ | ↑ | -/↑ | ↑ |
Other features | - | - | - | ADAMTS13 ≤10% | ADAMTS13 >10% | - | - | Hypoglycemia | Antibody to cardiolipin and/or β2 glycoprotein and/or lupus anticoagulant |
Adapted from Cines and Levine [1] Thrombocytopenia in pregnancy. Blood 2017;130:2271-7..
Abbreviations: AFLP, acute fatty liver of pregnancy; aHUS, atypical hemolytic uremic syndrome; ALT, alanine aminotransferase; APS, antiphospholipid syndrome; aPTT, activated partial thromboplastin time; AST, aspartate aminotransferase; CBC, complete blood count; GT, gestational thrombocytopenia; HELLP, hemolysis, elevated liver enzyme and low platelet count; HT, hereditary thrombocytopenia; ITP, immune thrombocytopenia; LDH, lactate dehydrogenase; PBS, peripheral blood smear; PEC, preeclampsia; PLT, platelet; PT, prothrombin time; TTP, thrombotic thrombocytopenic purpura; WBC, white blood cell..
Somayeh Sadeghi, Marjan Golshani, Bahareh Safaeian
Blood Res 2021; 56(3): 150-155Moon Ju Jang, Yun Ho Bae, So Yeon Oh, So Young Chong, Seung Ju Shin, Sung Woon Chang, Do yeun Oh
Korean J Hematol 2006; 41(4): 266-271Ka‑Won Kang
Blood Res 2024; 59():